Cutting-Edge Nanocarrier-Based Strategies in the Management of Leukaemia
Versandkostenfrei!
Erscheint vorauss. 1. Mai 2026
155,99 €
inkl. MwSt.
PAYBACK Punkte
78 °P sammeln!
Cutting-edge Nanocarrier-based Strategies in the Management of Leukaemia addresses the growing importance of nanocarriers in leukaemia treatment. It explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. This book fills a critical gap in current literature, serving as a valuable resource for researchers, clinicians, and students. This book begins with an introduction to leukemia, covering its epidemiology and risk factors. It then delves into innovative therapies and the use of various nanocarriers such as polymeric na...
Cutting-edge Nanocarrier-based Strategies in the Management of Leukaemia addresses the growing importance of nanocarriers in leukaemia treatment. It explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. This book fills a critical gap in current literature, serving as a valuable resource for researchers, clinicians, and students. This book begins with an introduction to leukemia, covering its epidemiology and risk factors. It then delves into innovative therapies and the use of various nanocarriers such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels. Additionally, it discusses precision medicine, AI in leukaemia care, and strategies to overcome treatment resistance, enriched with tables, figures, and images. Healthcare providers, including physicians, immunologists, oncologists, and pharmacists, will find this book invaluable. It educates on cutting-edge therapies and offers practical insights into personalized patient care, making it essential for those involved in leukaemia management.
Andere Kunden interessierten sich für
